Avalanche Biotechnologies
Latest round
- Series B
Last raised
- Apr 2014
Total raised
- $55M
Investors
- 6
About Avalanche Biotechnologies
Founded in 2006 and headquartered in Menlo Park, US, Avalanche Biotechnologies specializes in gene therapy solutions. Over the years, the company has pivoted towards ophthalmic applications, emphasizing its commitment to advancing medical treatment.Avalanche Biotechnologies develops gene therapy products designed to address ocular diseases. Their primary offerings focus on harnessing gene transfer technology to introduce therapeutic genes into target cells, potentially revolutionizing treatment for conditions such as inherited retinal diseases.5 mn.Looking ahead, Avalanche Biotechnologies aims to expand its portfolio of gene therapies with new products targeting additional eye diseases by 2025. The company plans to leverage the proceeds from its recent IPO to enhance R&D efforts and accelerate clinical trials for its leading candidates. Furthermore, the company is eyeing expansion into international markets, particularly in Europe and Asia, to broaden its patient reach and market presence.
Who invested in Avalanche Biotechnologies
6 investors across 1 round
See all investors in Avalanche Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 22, 2014
Amount
$55M
Investors
Questions about Avalanche Biotechnologies
Who invested in Avalanche Biotechnologies?
Avalanche Biotechnologies has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Avalanche Biotechnologies raised?
Avalanche Biotechnologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Avalanche Biotechnologies last raise money?
Avalanche Biotechnologies's most recent round on record is a Series B, in Apr 2014.
What does Avalanche Biotechnologies do?
Founded in 2006 and headquartered in Menlo Park, US, Avalanche Biotechnologies specializes in gene therapy solutions.
Where is Avalanche Biotechnologies headquartered?
Avalanche Biotechnologies is headquartered in Menlo Park, US.
Which VCs invest in companies like Avalanche Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Avalanche Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Avalanche Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.